Asia Medical and Agricultural Laboratory and Research Center Past Earnings Performance
Past criteria checks 1/6
Asia Medical and Agricultural Laboratory and Research Center's earnings have been declining at an average annual rate of -4.7%, while the Professional Services industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 9.5% per year. Asia Medical and Agricultural Laboratory and Research Center's return on equity is 1.9%, and it has net margins of 3.3%.
Key information
-4.7%
Earnings growth rate
-12.9%
EPS growth rate
Professional Services Industry Growth | 12.5% |
Revenue growth rate | 9.5% |
Return on equity | 1.9% |
Net Margin | 3.3% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Asia Medical and Agricultural Laboratory and Research Center makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 294 | 10 | 97 | 0 |
30 Sep 23 | 279 | 7 | 92 | 0 |
30 Jun 23 | 270 | 6 | 89 | 0 |
31 Mar 23 | 266 | 9 | 86 | 0 |
31 Dec 22 | 264 | 15 | 82 | 0 |
30 Sep 22 | 272 | 27 | 80 | 0 |
30 Jun 22 | 259 | 27 | 76 | 0 |
31 Mar 22 | 252 | 25 | 74 | 0 |
31 Dec 21 | 249 | 25 | 73 | 0 |
31 Dec 20 | 220 | 28 | 65 | 0 |
31 Dec 19 | 198 | 18 | 74 | 0 |
31 Dec 18 | 165 | 4 | 69 | 0 |
Quality Earnings: AMARC has high quality earnings.
Growing Profit Margin: AMARC's current net profit margins (3.3%) are lower than last year (5.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AMARC's earnings have declined by 4.7% per year over the past 5 years.
Accelerating Growth: AMARC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AMARC had negative earnings growth (-33.6%) over the past year, making it difficult to compare to the Professional Services industry average (4.7%).
Return on Equity
High ROE: AMARC's Return on Equity (1.9%) is considered low.